Send to printer »

Insight & Intelligence™ : Aug 21, 2012

Top 10 Pharma Firms

Check out which companies made the list.
  • Alex Philippidis

Below are Top 10 pharmaceutical companies based on market capitalization at the end of the second quarter 2012, and the year-ago quarter, calculated by multiplying the number of outstanding shares by the share price. U.S. companies generally report their numbers of outstanding shares in their 10-Q quarterly earnings filings with the Securities & Exchange Commission. Companies based outside the U.S. either disclose market cap directly, or their numbers of shares “in issue” or “in free issue” in half-year and full-year results disclosures.

For all companies, closing share prices as of the dates of their outstanding-shares figures can be found through any of several free stock information websites. Figures of non-U.S. companies were converted from various currencies.

#10. AstraZeneca

2012 Market Cap: $56.34 billion (6/30: 1.259 million shares * 6/29 price $44.75)

2011 Market Cap: $68.40 billion (6/30: 1.366 million shares * 6/30 price $50.07)

% Change: -17.6%

#9. Bristol-Myers Squibb

2012 Market Cap: $60.36 billion (6/30: 1,679,022,076 shares * 6/29 price $35.95)

2011 Market Cap: $49.40 billion (6/30: 1,705,666,684 shares * 6/30 price $28.96)

% Change: 22.2%

#8. Sanofi1

2012 Market Cap: $96.99 billion (6:30: 1,321,852,008 shares * 6/29 price €59.74 = €78,967,438,957.92)

2011 Market Cap: $91.95 billion (€E74.865 billion)

% Change: 4.7%

#7. Abbott Laboratories

2012 Market Cap: $101.17 billion (6/30: 1,569,333,729 shares * 6/29 price $64.47)

2011 Market Cap: $81.91 billion (6/30: 1,556,576,533 shares * 6/30 price $52.62)

% Change: 23.5%

#6. GlaxoSmithKline2

2012 Market Cap: $111.45 billion (4.91M shares *1,447p /100 & convert)

2011 Market Cap: $105.37 billion (5.036M shares *1,334p /100 & convert)

% Change: 5.8%

#5. Novartis3

2012 Market Cap: $133.9 billion

2011 Market Cap: $150.1 billion

% Change: -10.8%

#4. Merck & Co.

2012 Market Cap: $134.53 billion (7/31: 3,045,632,274 shares * price $44.17)

2011 Market Cap: $105.15 billion (7/29: 3,080,796,992 shares * price $34.13)

% Change: 27.9%

#3. Roche4

2012 Market Cap: $142.94 billion (CHF: 139.737M)

2011 Market Cap: $123.35 billion (CHF: 120.587M)

% Change: 15.9%

#2. Pfizer

2012 Market Cap: $181.21 billion (8/6: 7,469,483,622 shares * price $24.26)

2011 Market Cap: $129.98 billion (8/8: 7,802,126,616 shares * price $16.66)

% Change: 39.4%

#1. Johnson & Johnson

2012 Market Cap: $191.67 billion (7/27: 2,757,041,143 shares * price $69.52)

2011 Market Cap: $177.55 billion (7/29: 2,740,354,114 shares * price $64.79)

% Change: 8.0%

 

Leave a comment by clicking the “Comments” icon. We want to hear your thoughts!